• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种新型蛋白酪氨酸激酶,每种都带有一个与磷酸转移酶相关的第二催化结构域,它们定义了一类新的蛋白激酶。

Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.

作者信息

Wilks A F, Harpur A G, Kurban R R, Ralph S J, Zürcher G, Ziemiecki A

机构信息

Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria, Australia.

出版信息

Mol Cell Biol. 1991 Apr;11(4):2057-65. doi: 10.1128/mcb.11.4.2057-2065.1991.

DOI:10.1128/mcb.11.4.2057-2065.1991
PMID:1848670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC359893/
Abstract

The protein-tyrosine kinases (PTKs) are a burgeoning family of proteins, each of which bears a conserved domain of 250 to 300 amino acids capable of phosphorylating substrate proteins on tyrosine residues. We recently exploited the existence of two highly conserved sequence elements within the catalytic domain to generate PTK-specific degenerate oligonucleotide primers (A. F. Wilks, Proc. Natl. Acad. Sci. USA 86:1603-1607, 1989). By application of the polymerase chain reaction, portions of the catalytic domains of several novel PTKs were amplified. We describe here the primary sequence of one of these new PTKs, JAK1 (from Janus kinase), a member of a new class of PTK characterized by the presence of a second phosphotransferase-related domain immediately N terminal to the PTK domain. The second phosphotransferase domain bears all the hallmarks of a protein kinase, although its structure differs significantly from that of the PTK and threonine/serine kinase family members. A second member of this family (JAK2) has been partially characterized and exhibits a similar array of kinase-related domains. JAK1 is a large, widely expressed membrane-associated phosphoprotein of approximately 130,000 Da. The PTK activity of JAK1 has been located in the C-terminal PTK-like domain. The role of the second kinaselike domain is unknown.

摘要

蛋白质酪氨酸激酶(PTK)是一个新兴的蛋白质家族,每个成员都有一个由250至300个氨基酸组成的保守结构域,能够使底物蛋白的酪氨酸残基发生磷酸化。我们最近利用催化结构域内两个高度保守的序列元件,设计了PTK特异性简并寡核苷酸引物(A.F.威尔克斯,《美国国家科学院院刊》86:1603 - 1607, 1989)。通过聚合酶链反应,扩增出了几种新型PTK催化结构域的部分片段。我们在此描述其中一种新的PTK,即JAK1(源自Janus激酶)的一级序列,它是一类新型PTK的成员,其特征是在PTK结构域紧邻的N端存在第二个与磷酸转移酶相关的结构域。第二个磷酸转移酶结构域具有蛋白激酶的所有特征,尽管其结构与PTK及苏氨酸/丝氨酸激酶家族成员的结构有显著差异。该家族的另一个成员(JAK2)已得到部分特征描述,并表现出类似的一系列与激酶相关的结构域。JAK1是一种分子量约为130,000 Da的大型、广泛表达的膜相关磷蛋白。JAK1的PTK活性位于C端类似PTK的结构域。第二个类似激酶的结构域的作用尚不清楚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7132/359893/ea71fcf6a238/molcellb00138-0298-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7132/359893/9bd7ae540c75/molcellb00138-0294-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7132/359893/ea71fcf6a238/molcellb00138-0298-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7132/359893/9bd7ae540c75/molcellb00138-0294-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7132/359893/ea71fcf6a238/molcellb00138-0298-a.jpg

相似文献

1
Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.两种新型蛋白酪氨酸激酶,每种都带有一个与磷酸转移酶相关的第二催化结构域,它们定义了一类新的蛋白激酶。
Mol Cell Biol. 1991 Apr;11(4):2057-65. doi: 10.1128/mcb.11.4.2057-2065.1991.
2
Two additional protein-tyrosine kinases expressed in human lung: fourth member of the fibroblast growth factor receptor family and an intracellular protein-tyrosine kinase.在人肺中表达的另外两种蛋白酪氨酸激酶:成纤维细胞生长因子受体家族的第四个成员和一种细胞内蛋白酪氨酸激酶。
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10411-5. doi: 10.1073/pnas.88.23.10411.
3
Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases.大鼠JAK3的分子克隆,蛋白酪氨酸激酶JAK家族的一个新成员。
FEBS Lett. 1994 Apr 4;342(2):124-8. doi: 10.1016/0014-5793(94)80485-0.
4
Spk1, a new kinase from Saccharomyces cerevisiae, phosphorylates proteins on serine, threonine, and tyrosine.Spk1是一种来自酿酒酵母的新型激酶,可使蛋白质的丝氨酸、苏氨酸和酪氨酸发生磷酸化。
Mol Cell Biol. 1991 Feb;11(2):987-1001. doi: 10.1128/mcb.11.2.987-1001.1991.
5
Novel protein kinase of Arabidopsis thaliana (APK1) that phosphorylates tyrosine, serine and threonine.拟南芥的新型蛋白激酶(APK1),可磷酸化酪氨酸、丝氨酸和苏氨酸。
Plant Mol Biol. 1992 Nov;20(4):653-62. doi: 10.1007/BF00046450.
6
Hydrophobic Core Variations Provide a Structural Framework for Tyrosine Kinase Evolution and Functional Specialization.疏水核心变异为酪氨酸激酶的进化和功能特化提供了结构框架。
PLoS Genet. 2016 Feb 29;12(2):e1005885. doi: 10.1371/journal.pgen.1005885. eCollection 2016 Feb.
7
Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction.通过聚合酶链反应鉴定出两种假定的蛋白酪氨酸激酶。
Proc Natl Acad Sci U S A. 1989 Mar;86(5):1603-7. doi: 10.1073/pnas.86.5.1603.
8
RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs.RYK,一种具有异常激酶结构域基序的受体酪氨酸激酶相关分子。
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11818-22. doi: 10.1073/pnas.89.24.11818.
9
JAK2, a third member of the JAK family of protein tyrosine kinases.JAK2,蛋白酪氨酸激酶JAK家族的第三个成员。
Oncogene. 1992 Jul;7(7):1347-53.
10
Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII.Dyrk是一种具有独特结构特征的双特异性蛋白激酶,其活性依赖于亚结构域VII和VIII之间的酪氨酸残基。
J Biol Chem. 1996 Feb 16;271(7):3488-95. doi: 10.1074/jbc.271.7.3488.

引用本文的文献

1
Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel Disease.迈向精准医学:炎症性肠病中对托法替布反应的分子生物标志物
Genes (Basel). 2025 Jul 29;16(8):908. doi: 10.3390/genes16080908.
2
ERH regulates type II interferon immune signaling through post-transcriptional regulation of JAK2 mRNA.ERH通过对JAK2 mRNA的转录后调控来调节II型干扰素免疫信号通路。
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf545.
3
JAK-STAT Signaling in Autoimmunity and Cancer.自身免疫与癌症中的JAK-STAT信号传导

本文引用的文献

1
A simple method for displaying the hydropathic character of a protein.一种展示蛋白质亲水性特征的简单方法。
J Mol Biol. 1982 May 5;157(1):105-32. doi: 10.1016/0022-2836(82)90515-0.
2
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.真核生物mRNA翻译起始位点上游序列的汇编与分析。
Nucleic Acids Res. 1984 Jan 25;12(2):857-72. doi: 10.1093/nar/12.2.857.
3
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.
Immunotargets Ther. 2025 May 11;14:523-554. doi: 10.2147/ITT.S485670. eCollection 2025.
4
Sometimes Small Is Beautiful: Discovery of the Janus Kinases (JAK) and Signal Transducer and Activator of Transcription (STAT) Pathways and the Initial Development of JAK Inhibitors for IBD Treatment.有时小即是美:Janus激酶(JAK)和信号转导及转录激活因子(STAT)通路的发现以及用于炎症性肠病治疗的JAK抑制剂的初步研发
Dig Dis Sci. 2025 Mar;70(3):890-898. doi: 10.1007/s10620-024-08791-1. Epub 2025 Jan 18.
5
A Software Tool for Reagent Design to Expand Access to Single-Nucleotide Variant Detection by the Oligonucleotide Ligation Assay.一种用于试剂设计的软件工具,可通过寡核苷酸连接测定法扩大单核苷酸变异检测的可及性。
J Mol Diagn. 2025 Mar;27(3):184-198. doi: 10.1016/j.jmoldx.2024.12.007. Epub 2025 Jan 14.
6
JAK inhibitor selectivity: new opportunities, better drugs?JAK 抑制剂选择性:新机遇,更好的药物?
Nat Rev Rheumatol. 2024 Oct;20(10):649-665. doi: 10.1038/s41584-024-01153-1. Epub 2024 Sep 9.
7
The JAK-STAT pathway: from structural biology to cytokine engineering.JAK-STAT 通路:从结构生物学到细胞因子工程。
Signal Transduct Target Ther. 2024 Aug 21;9(1):221. doi: 10.1038/s41392-024-01934-w.
8
Age-associated myeloid malignancies - the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia.年龄相关性髓系恶性肿瘤 - STAT3 和 STAT5 在骨髓增生异常综合征和急性髓系白血病中的作用。
FEBS Lett. 2024 Nov;598(22):2809-2828. doi: 10.1002/1873-3468.14985. Epub 2024 Jul 24.
9
Mutual regulations between and type I interferon.与 I 型干扰素的相互调节。
Front Immunol. 2024 Jul 8;15:1428232. doi: 10.3389/fimmu.2024.1428232. eCollection 2024.
10
JAK-Inhibitors - A Story of Success and Adverse Events.JAK抑制剂——成功与不良事件的故事
Open Access Rheumatol. 2024 Feb 26;16:43-53. doi: 10.2147/OARRR.S436637. eCollection 2024.
人表皮生长因子受体cDNA序列及扩增基因在A431表皮样癌细胞中的异常表达。
Nature. 1984;309(5967):418-25. doi: 10.1038/309418a0.
4
Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of P130gag-fps modulates its biological activity.藤浪肉瘤病毒的诱变:P130gag-fps的酪氨酸磷酸化调节其生物学活性的证据。
Cell. 1984 Jun;37(2):559-68. doi: 10.1016/0092-8674(84)90386-6.
5
Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus.与莫洛尼氏鼠肉瘤病毒转化基因(mos)同源的人类DNA序列。
Proc Natl Acad Sci U S A. 1982 Jul;79(13):4078-82. doi: 10.1073/pnas.79.13.4078.
6
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
7
Construction of phylogenetic trees.系统发育树的构建。
Science. 1967 Jan 20;155(3760):279-84. doi: 10.1126/science.155.3760.279.
8
The structure of the human c-fes/fps proto-oncogene.人类c-fes/fps原癌基因的结构
EMBO J. 1985 Nov;4(11):2897-903. doi: 10.1002/j.1460-2075.1985.tb04020.x.
9
Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2.利用互补作用克隆了裂殖酵母细胞周期控制基因cdc2的一个人类同源基因。
Nature. 1987;327(6117):31-5. doi: 10.1038/327031a0.
10
Nucleotide sequence of the yeast regulatory gene STE7 predicts a protein homologous to protein kinases.酵母调节基因STE7的核苷酸序列预测出一种与蛋白激酶同源的蛋白质。
Proc Natl Acad Sci U S A. 1986 Oct;83(19):7371-5. doi: 10.1073/pnas.83.19.7371.